Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D92IFQ
|
|||
| Drug Name |
mRNA-1020
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza [ICD-11: 1E30-1E32; ICD-10: J10, J11; ICD-9: 487, 488] | Phase 2 | [1] | |
| Company |
Moderna
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05333289) Phase 1/2, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1020 and mRNA-1030 Candidate Seasonal Influenza Vaccines in Healthy Adults. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.